DeepSynapsCLINICAL INTELLIGENCE OS
Questions

Questions about DeepSynaps Clinical Intelligence OS

Who the clinical beta is for, what teams can explore first, how applications are reviewed and what the platform does and does not do.

Who is the clinical beta for?

Clinicians, qEEG and neuromodulation teams, clinic owners and researchers working in mental health and neuromodulation. Developers and integration partners can also apply. Access is reviewed by the DeepSynaps team.

What can my team explore first?

Phase 1 focuses on qEEG reports and approved Neuromodulation Studio templates, supported by patient management, scheduling, inbox and evidence workflows. The wider analyzer, Twin and Studio catalog shows the platform direction; access varies by capability.

What happens after I apply?

The DeepSynaps team reviews your role, organisation and workflow, then follows up about fit and available access. Applications open access in small cohorts. Applying does not automatically create a professional account.

Is every NERVE available now?

Mental Health & Neuromodulation is the current focus. Grey specialty NERVEs show future directions. The neural map explains how data, analyzers, Twins and workspaces connect; it is an interactive product illustration, not a live model of a patient’s brain.

Can the platform make clinical decisions for me?

The platform supports qualified professionals with review and workflow tools. It does not provide medical advice or replace independent clinical judgement. Clinicians remain responsible for clinical decisions, including neuromodulation planning and report release.

Should I include patient information in my application?

No. Use the application only to describe your professional role and organisation. Do not enter patient-identifiable information on this public page. Clinical data access is handled separately through the appropriate organisation, consent and access arrangements.

Do I need payment details to apply?

No payment details are needed to apply. Beta availability, scope and any applicable commercial terms are confirmed with your team during the review process.

Another question? Contact ali.yildirim@deepsynaps.com.